Stock XSPRAY XSPRAY PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Xspray Pharma AB

Equities

XSPRAY

SE0009973563

Delayed Nasdaq Stockholm
Other stock markets
 05:31:49 2024-06-10 am EDT 		5-day change 1st Jan Change
73.6 SEK +2.51% Intraday chart for Xspray Pharma AB -1.08% +84.00%
May. 23 Xspray Pharma AB Announces to Present Data At ASCO Highlighting Frequent Decideication of PPIs with TKIs in CML-Patients and Greater Than Expected Positive Effects on the Bioavailability of Crystalline Dasatinib CI
May. 20 Xspray Pharma AB Appoints Linda Glimberg as Chief Operating Officer, Effective June 1, 2024 CI

Evolution of the average Target Price on Xspray Pharma AB

Price target over the last 5 years

History of analyst recommendation changes

b169bc09a8e6660e33444e67ea11c55.PrpLsuoZFnGmJ14M4gI3Og_zbERGvQPOVDZ960m68UE.av1_9JhtTkieV3NdkXFxAjyaKA8fimH8InUVuS_QnisT8SaD32FyNMN-MQ~c84c4ed4087951cf6c74b6de0a1a601b

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
71.8 SEK
Average target price
107 SEK
Spread / Average Target
+49.03%
High Price Target
107 SEK
Spread / Highest target
+49.03%
Low Price Target
107 SEK
Spread / Lowest Target
+49.03%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XSPRAY Stock
  4. Consensus Xspray Pharma AB